Maze Therapeutics MAZE
NASDAQ MAZE
$32.58 +0.13 (+0.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026)

Updated

Maze Therapeutics' (MAZE) Asset Utilization Ratio came in at 0.04 for Q2 2026, up 435.1% from 0.01 a year earlier but down 14.1% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Since Q1 2025, Maze Therapeutics has reported Asset Utilization Ratio for 4 quarters.

  • Quarterly Asset Utilization Ratio has run from a low of 0.01 in Q2 2025 to a high of 0.58 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Maze Therapeutics 1.92 Bn 434.24 Mn - 0.04
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.05
Jun 30, 2025 0.01
Mar 31, 2025 0.58
API Access

Maze Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=MAZE&period=max&api_key=YOUR_API_KEY